Abstract: The present invention provides a multi-stage system for treating greywater comprising an electrochemical treatment module configured to carry out electrooxidation and electrocoagulation processes and a filtration module comprising a multistage filtration system for the treatment and removal of chemical and biological contaminants in greywater.

Abstract: Aspects described herein relate to a method comprising: receiving a request to write data to a persistent storage device, the request comprising data; determining an affinity of the data; writing the request to a cache line of a cache; associating the cache line with the affinity of the data; and reporting the data as having been written to the persistent storage device.

Abstract: A compound represented by the general formula (1) or a salt thereof, which has a superior IRAK-4 inhibitory activity, and is useful as active ingredients of medicaments for prophylactic treatment and/or therapeutic treatment of diseases relating to IRAK-4 inhibition.

Abstract: The present disclosure relates to compositions and methods for inducing an adaptive immune response against Hepatitis C virus (HCV) in a subject. In some embodiments, the present disclosure provides a composition comprising a nucleic acid molecule encoding a HCV antigen, an HCV antigen, an adjuvant, or a combination thereof. For example, in some embodiments, the composition comprises a vaccine comprising a nucleic acid molecule encoding a HCV antigen, an HCV antigen, an adjuvant, or a combination thereof.

Abstract: The present disclosure relates to compositions and methods for inducing an adaptive immune response against Hepatitis C virus (HCV) in a subject. In some embodiments, the present disclosure provides a composition comprising a nucleic acid molecule encoding a HCV antigen, an HCV antigen, an adjuvant, or a combination thereof. For example, in some embodiments, the composition comprises a vaccine comprising a nucleic acid molecule encoding a HCV antigen, an HCV antigen, an adjuvant, or a combination thereof.

Abstract: Compounds of formula (I): wherein Ra, Rb, Rc, Rd, R3, R4, R5, A1, A2, T and W are as defined in the description. Medicinal products containing the same which are useful in treating conditions requiring a pro-apoptotic agent.

Abstract: A blending device (2) for blending a sample held in a sealable open mouthed sample bag comprises a bag receiving portion (6). The blending device (2) also includes a kneading arrangement (20) for acting on a wall of a sample bag (8) disposed in the bag receiving portion (6) so as to blend a sample contained in the bag (8). A bag manipulation arrangement (13) or a bag support (28) may also be provided.

Abstract: Compounds of formula (I): wherein R1, R2, W3, W4, A1, and A2 are as defined in the description. Medicinal products containing the same which are useful in treating cancer, neurodegenerative disorders and metabolic disorders.

Abstract: Compounds of formula (I): wherein Ra, Rb, Rc, Rd, R3, R4, R5, A1, A2, T and W are as defined in the description. Medicinal products containing the same which are useful in treating conditions requiring a pro-apoptotic agent.

Abstract: Techniques are described for providing graphics functionality. In a first partition, a software interface comprising graphics capabilities that are abstracted from capabilities of the graphics accelerator device is loaded. In a second partition loading, a graphics capturing and rendering process is loaded. The software interface on the first partition receives a request to render graphics. The request is based on the abstracted graphics capabilities. The graphics capturing and rendering process renders the requested graphics on the second partition. The abstracted graphics capabilities are effectuated in accordance with the capabilities of the graphics accelerator device. The capturing process executing on the second partition provides the rendered graphics to the first partition.

Abstract: Compounds of formula (I): wherein Ra, Rb, Rc, Rd, R3, R4, R5, A1, A2, T and W are as defined in the description. Medicinal products containing the same which are useful in treating pathologies involving a deficit in apoptosis, such as cancer, auto-immune diseases, and diseases of the immune system.

Abstract: Methods of providing a recipe service are provided. The method is associated with a server including a processor therein, the processor is configured to receive input from a user, the input being associated with a recipe; customize a list of items defining the recipe based on parameters associated with the user and/or input received from the user in real time; automatically populate a shopping list with the customized list of items defining the recipe for purchase by the user; modify the shopping list responsive to user input; and provide the modified shopping list for use by the user to purchase the items on the modified shopping list. Related devices and computer program products are provided.

Abstract: A blending device (2) for blending a sample held in a sealable open mouthed sample bag comprises a bag receiving portion (6). The blending device (2) also includes a kneading arrangement (20) for acting on a wall of a sample bag (8) disposed in the bag receiving portion (6) so as to blend a sample contained in the bag (8). A bag manipulation arrangement (13) or a bag support (28) may also be provided.

Abstract: Compounds of formula (I): wherein Ra, Rb, Rc, Rd, R3, R4, R5, A1, A2, T and W are as defined in the description. Medicinal products containing the same which are useful in treating pathologies involving a deficit in apoptosis, such as cancer, auto-immune diseases, and diseases of the immune system.

Abstract: Various techniques for remoting graphics are described in the claims, drawings, and text forming a part of the present disclosure.

Abstract: A blending device (2) for blending a sample held in a sealable open mouthed sample bag comprises a bag receiving portion (6). The blending device (2) also includes a kneading arrangement (20) for acting on a wall of a sample bag (8) disposed in the bag receiving portion (6) so as to blend a sample contained in the bag (8). A bag manipulation arrangement (13) or a bag support (28) may also be provided.

Abstract: Various techniques for remoting graphics are described in the claims, drawings, and text forming a part of the present disclosure.

Abstract: Methods and systems are disclosed for virtualizing a graphics accelerator such as a GPU. In one embodiment, a GPU can be paravirtualized. Rather than modeling a complete hardware GPU, paravirtualization may provide for an abstracted software-only GPU that presents a software interface different from that of the underlying hardware. By providing a paravirtualized GPU, a virtual machine may enable a rich user experience with, for example, accelerated 3D rendering and multimedia, without the need for the virtual machine to be associated with a particular GPU product.

Abstract: Various techniques for remoting graphics are described in the claims, drawings, and text forming a part of the present disclosure.